Skip to content

Optimizing Surgical Conditions During Gynecologic Laparoscopic Surgery With Deep Neuromuscular Blockade

Optimizing Surgical Conditions: Intraabdominal Distance During Gynecologic Laparoscopic Surgery With and Without Muscle Relaxation (The Measurement Study)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01933425
Enrollment
14
Registered
2013-09-02
Start date
2013-08-31
Completion date
2014-04-30
Last updated
2015-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade

Keywords

surgical conditions, laparoscopy

Brief summary

To investigate if deep neuromuscular blockade improves intraabdominal volume compared to no neuromuscular blockade in patients scheduled for gynecologic laparoscopic surgery with pneumoperitoneum 12 mmHg. Hypothesis: Deep neuromuscular blockade improves intraabdominal space (the distance from promontorium to skin surface, cm) compared to no neuromuscular blockade.

Interventions

DRUGrocuronium
DRUGsugammadex
DRUGplacebo

Sponsors

Herlev Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients \> 18 years old * elective laparoscopic operation * can read and understand Danish * informed consent

Exclusion criteria

* BMI \> 30 kg/cm2 * known allergy to medications that are included in the project, * severe renal disease, defined by S-creatinine\> 0,200 mmol/L, GFR \< 30ml/min or hemodialysis), * neuromuscular disease that may interfere with neuromuscular data, * lactating or pregnant, * impaired liver function, * converting to laparotomy, * perioperative use of neuromuscular blocking agents before randomization, * pneumoperitoneum set to \>12 mmHg on the insufflator

Design outcomes

Primary

MeasureTime frameDescription
Intraabdominal Distance (Centimeters)1 hourDifference in intraabdominal distance from promontorium to the edge of the trocar in umbilicus at 12 mmHg with and without deep neuromuscular blockade (PTC 0-1).

Secondary

MeasureTime frameDescription
Intraabdominal Distance (Centimeters)1 hourDifference in intraabdominal distance from promontorium to the edge of the trocar in umbilicus at 8 mmHg with and without deep neuromuscular blockade (PTC 0-1).
Surgical Conditions During Suturing of the Abdominal Fascia1 hourOptimal (score 1) Good (score 2) Acceptable (score 3) Poor (score 4)

Countries

Denmark

Participant flow

Recruitment details

Carried out between November 2013 and April 2014. Center for Minimal Invasive Gynaecology, Aleris-Hamlet Hospital Copenhagen, Denmark. A total of 25 patients were eligible in the study period, of which nine declined to participate, and two were excluded due to the fact that they did not speak Danish. All 14 patients completed the study

Participants by arm

ArmCount
Patient Characteristics in 14 Women14
Total14

Baseline characteristics

CharacteristicPatient Characteristics in 14 Women
Age, Continuous44.2 years
STANDARD_DEVIATION 7.7
BMI22.2 kg/m2
STANDARD_DEVIATION 2.6
Number of patients with 0 pregnancies6 participants
Number of patients with 1 pregnancy3 participants
Number of patients with 2 pregnancies2 participants
Number of patients with 3 pregnancies3 participants
Number of patients with previous abdominal surgery7 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 70 / 7
serious
Total, serious adverse events
0 / 70 / 7

Outcome results

Primary

Intraabdominal Distance (Centimeters)

Difference in intraabdominal distance from promontorium to the edge of the trocar in umbilicus at 12 mmHg with and without deep neuromuscular blockade (PTC 0-1).

Time frame: 1 hour

Population: Comparisons of changes in distances were performed with paired t-test.

ArmMeasureValue (MEDIAN)
Deep Neuromuscular BlockIntraabdominal Distance (Centimeters)9.3 centimeters
No Neuromuscular BlockIntraabdominal Distance (Centimeters)9.0 centimeters
p-value: <0.0595% CI: [0.07, 0.59]t-test, 2 sided
Secondary

Intraabdominal Distance (Centimeters)

Difference in intraabdominal distance from promontorium to the edge of the trocar in umbilicus at 8 mmHg with and without deep neuromuscular blockade (PTC 0-1).

Time frame: 1 hour

Population: Comparisons of changes in distances were performed with paired t-test

ArmMeasureValue (MEDIAN)
Deep Neuromuscular BlockIntraabdominal Distance (Centimeters)8.6 centimeters
No Neuromuscular BlockIntraabdominal Distance (Centimeters)8.2 centimeters
p-value: <0.0595% CI: [0.06, 0.54]t-test, 2 sided
Secondary

Surgical Conditions During Suturing of the Abdominal Fascia

Optimal (score 1) Good (score 2) Acceptable (score 3) Poor (score 4)

Time frame: 1 hour

Population: Evaluation of surgical conditions was compared using Mann-Whitney U-test.

ArmMeasureGroupValue (NUMBER)
Deep Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaOptimal (score 1)7 participants
Deep Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaAcceptable (score 3)0 participants
Deep Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaPoor (score 4)0 participants
Deep Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaGood (score 2)0 participants
No Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaPoor (score 4)0 participants
No Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaOptimal (score 1)2 participants
No Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaGood (score 2)5 participants
No Neuromuscular BlockSurgical Conditions During Suturing of the Abdominal FasciaAcceptable (score 3)0 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026